English

PAVMED INC.

EDGAR

PAVM Current report (8-K) · filed 2026-10-22

Annual consolidated revenue for 2025: about USD 71K, using the latest reported figures. The previous period, 2024, was about USD 2.995M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

33 thousand USD

2026 Q2 · USD

Exact inputs and evidence

Revenue: 33000 USD Source

Operating margin

-21,278.79%

2026 Q2 · %

Exact inputs and evidence

Operating Income: -7022000 USD Source
Revenue: 33000 USD Source

Operating cash flow

-2.7 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -5300000 USD Source
Operating Cash Flow: -2600000 USD Source

Free cash flow

-2.71 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -5300000 USD Source
Operating Cash Flow: -2600000 USD Source
Capital Expenditure: 35000 USD Source
Capital Expenditure: 22000 USD Source

Cash and cash equivalents: 3.78 million USD 2026-06-30 Source
Exact value

3784000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 6.27 million shares 2026-06-30 Source
Exact value

6269418 shares

Reported share-count change

-68.87% · -13.9 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

20142463 shares · 2025-06-30· Source
6269418 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

112 thousand USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Revenue: 5000 USD · 2025-07-01 – 2025-09-30 Source
Revenue: 71000 USD · 2025-01-01 – 2025-12-31 Source
Revenue: 19000 USD · 2025-01-01 – 2025-09-30 Source
Revenue: 22000 USD · 2026-01-01 – 2026-03-31 Source
Revenue: 33000 USD · 2026-04-01 – 2026-06-30 Source

Net income

-12.1 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -5383000 USD · 2025-07-01 – 2025-09-30 Source
Net income: 401000 USD · 2025-01-01 – 2025-12-31 Source
Net income: 1664000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -60000 USD · 2026-01-01 – 2026-03-31 Source
Net income: -5384000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-7.74 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -3700000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -2759000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -5200000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -3700000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -2600000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -5300000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -2600000 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

52 thousand USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Capital expenditure: 17000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 14000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 31000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 17000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 22000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 35000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 22000 USD · 2026-01-01 – 2026-03-31 Source

Free cash flow

-7.79 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -3700000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -2759000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -5200000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -3700000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -2600000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -5300000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -2600000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 17000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 14000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 31000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 17000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 22000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 35000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 22000 USD · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-22.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 2025-12-31
Operating income: 10 of 11 periods available· newest 2025-12-31
Net income: 11 of 11 periods available· newest 2025-12-31
Operating cash flow: 11 of 11 periods available· newest 2025-12-31
Capital expenditure: 10 of 11 periods available· newest 2025-12-31
Total assets: 5 of 11 periods available· newest 2025-12-31
Total liabilities: 5 of 11 periods available· newest 2025-12-31
Current assets: 5 of 11 periods available· newest 2025-12-31
Current liabilities: 5 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 5 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: 5 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-97.6%

Prior period

USD 3 million

2024-01-01 – 2024-12-31
Current period

USD 71,000

2025-01-01 – 2025-12-31

Exact inputs and evidence

71000 − 2995000 = -2924000 USD

2995000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
71000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · PAVMED INC. · 2025-12-31 PAVMED INC. (edgar:1624326) Year-over-year change in Revenue: -2924000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 71000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000143774926010115/pavm20251231_10k.htm#2005613 Filing: 000143774926010115 Input fundies:Revenue: 2995000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000143774926010115/pavm20251231_10k.htm#2006127 Filing: 000143774926010115
The citation records this snapshot. The page link may show a newer release later.
Net income
-99%

Prior period

USD 39.79 million

2024-01-01 – 2024-12-31
Current period

USD 401,000

2025-01-01 – 2025-12-31

Exact inputs and evidence

401000 − 39791000 = -39390000 USD

39791000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
401000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · PAVMED INC. · 2025-12-31 PAVMED INC. (edgar:1624326) Year-over-year change in Net income: -39390000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 401000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000143774926010115/pavm20251231_10k.htm#2953936 Filing: 000143774926010115 Input fundies:NetIncome: 39791000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000143774926010115/pavm20251231_10k.htm#2954932 Filing: 000143774926010115
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 28.35 million

Prior period

−USD 33.55 million

2024-01-01 – 2024-12-31
Current period

−USD 5.2 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-5200000 − -33554000 = 28354000 USD

-33554000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-5200000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · PAVMED INC. · 2025-12-31 PAVMED INC. (edgar:1624326) Year-over-year change in Operating cash flow: 28354000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -5200000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000143774926010115/pavm20251231_10k.htm#1825710 Filing: 000143774926010115 Input fundies:OperatingCashFlow: -33554000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000143774926010115/pavm20251231_10k.htm#1770146 Filing: 000143774926010115
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-43.6%

Prior period

USD 55,000

2024-01-01 – 2024-12-31
Current period

USD 31,000

2025-01-01 – 2025-12-31

Exact inputs and evidence

31000 − 55000 = -24000 USD

55000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
31000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · PAVMED INC. · 2025-12-31 PAVMED INC. (edgar:1624326) Year-over-year change in Capital expenditure: -24000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 31000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000143774926010115/pavm20251231_10k.htm#1774540 Filing: 000143774926010115 Input fundies:CapitalExpenditure: 55000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000143774926010115/pavm20251231_10k.htm#1775527 Filing: 000143774926010115
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 71,000 100% of revenue
Operating costs Derived USD 21.88 million 30,813% of revenue
Operating income −USD 21.81 million −30,713% of revenue
Tax, interest and other Derived −USD 22.21 million −31,277% of revenue
Net income USD 401,000 565% of revenue

Cash

Operating cash flow −USD 5.2 million −7,324% of revenue
Capital expenditure USD 31,000 44% of revenue
Free cash flow Derived −USD 5.23 million −7,368% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2021 Operating loss: operating costs were 10,979% of revenue.
2022 Operating loss: operating costs were 24,261% of revenue.
2023 Operating loss: operating costs were 2,906% of revenue.
2024 Operating loss: operating costs were 1,585% of revenue.
2025 Operating loss: operating costs were 30,813% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2021 2021-01-01 – 2021-12-31	500000	54893000 Derived	-54393000	-4046000 Derived	-50347000	-42060000 Derived	Source 2021-01-01 – 2021-12-31: 500000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -54393000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -50347000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -40591000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 1469000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	377000	91464000 Derived	-91087000	-2104000 Derived	-88983000	-72525000 Derived	Source 2022-01-01 – 2022-12-31: 377000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -91087000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -88983000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -70985000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 1540000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	2452000	71247000 Derived	-68795000	-4620000 Derived	-64175000	-52278000 Derived	Source 2023-01-01 – 2023-12-31: 2452000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -68795000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -64175000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -52036000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 242000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	2995000	47482000 Derived	-44487000	-84278000 Derived	39791000	-33609000 Derived	Source 2024-01-01 – 2024-12-31: 2995000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -44487000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: 39791000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -33554000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 55000 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	71000	21877000 Derived	-21806000	-22207000 Derived	401000	-5231000 Derived	Source 2025-01-01 – 2025-12-31: 71000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -21806000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: 401000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: -5200000 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 31000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 71K 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20212021-12-31	Revenue	500000	Revenue: 500000 Open source
20222022-12-31	Revenue	377000	Revenue: 377000 Open source
20232023-12-31	Revenue	2452000	Revenue: 2452000 Open source
20242024-12-31	Revenue	2995000	Revenue: 2995000 Open source
20252025-12-31	Revenue	71000	Revenue: 71000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-97.6% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20212021-12-31	Year over year	No prior comparable period	Revenue: 500000 Open source
20222022-12-31	Year over year	-24.6%	Revenue: 377000 Open source Revenue: 500000 Open source
20232023-12-31	Year over year	550.4%	Revenue: 2452000 Open source Revenue: 377000 Open source
20242024-12-31	Year over year	22.1%	Revenue: 2995000 Open source Revenue: 2452000 Open source
20252025-12-31	Year over year	-97.6%	Revenue: 71000 Open source Revenue: 2995000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -30,712.7% 2025

Net margin 564.8% 2025

Free cash flow margin -7,367.6% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20212021-12-31	Operating margin	-10,878.6%	Operating Income: -54393000 Open source Revenue: 500000 Open source
20222022-12-31	Operating margin	-24,161%	Operating Income: -91087000 Open source Revenue: 377000 Open source
20232023-12-31	Operating margin	-2,805.7%	Operating Income: -68795000 Open source Revenue: 2452000 Open source
20242024-12-31	Operating margin	-1,485.4%	Operating Income: -44487000 Open source Revenue: 2995000 Open source
20252025-12-31	Operating margin	-30,712.7%	Operating Income: -21806000 Open source Revenue: 71000 Open source
20212021-12-31	Net margin	-10,069.4%	Net Income: -50347000 Open source Revenue: 500000 Open source
20222022-12-31	Net margin	-23,602.9%	Net Income: -88983000 Open source Revenue: 377000 Open source
20232023-12-31	Net margin	-2,617.3%	Net Income: -64175000 Open source Revenue: 2452000 Open source
20242024-12-31	Net margin	1,328.6%	Net Income: 39791000 Open source Revenue: 2995000 Open source
20252025-12-31	Net margin	564.8%	Net Income: 401000 Open source Revenue: 71000 Open source
20212021-12-31	Free cash flow margin	-8,412%	Revenue: 500000 Open source Operating Cash Flow: -40591000 Open source Capital Expenditure: 1469000 Open source
20222022-12-31	Free cash flow margin	-19,237.4%	Revenue: 377000 Open source Operating Cash Flow: -70985000 Open source Capital Expenditure: 1540000 Open source
20232023-12-31	Free cash flow margin	-2,132.1%	Revenue: 2452000 Open source Operating Cash Flow: -52036000 Open source Capital Expenditure: 242000 Open source
20242024-12-31	Free cash flow margin	-1,122.2%	Revenue: 2995000 Open source Operating Cash Flow: -33554000 Open source Capital Expenditure: 55000 Open source
20252025-12-31	Free cash flow margin	-7,367.6%	Revenue: 71000 Open source Operating Cash Flow: -5200000 Open source Capital Expenditure: 31000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -5.2M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20212021-12-31	Operating cash flow	-40591000	Operating Cash Flow: -40591000 Open source
20222022-12-31	Operating cash flow	-70985000	Operating Cash Flow: -70985000 Open source
20232023-12-31	Operating cash flow	-52036000	Operating Cash Flow: -52036000 Open source
20242024-12-31	Operating cash flow	-33554000	Operating Cash Flow: -33554000 Open source
20252025-12-31	Operating cash flow	-5200000	Operating Cash Flow: -5200000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -5.2M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20212021-12-31	Free cash flow	-42060000	Operating Cash Flow: -40591000 Open source Capital Expenditure: 1469000 Open source
20222022-12-31	Free cash flow	-72525000	Operating Cash Flow: -70985000 Open source Capital Expenditure: 1540000 Open source
20232023-12-31	Free cash flow	-52278000	Operating Cash Flow: -52036000 Open source Capital Expenditure: 242000 Open source
20242024-12-31	Free cash flow	-33609000	Operating Cash Flow: -33554000 Open source Capital Expenditure: 55000 Open source
20252025-12-31	Free cash flow	-5231000	Operating Cash Flow: -5200000 Open source Capital Expenditure: 31000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

42.5% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20212021-12-31	Liabilities / assets	8.7%	Total Liabilities: 7558000 Open source Total Assets: 86976000 Open source
20222022-12-31	Liabilities / assets	79.7%	Total Liabilities: 43046000 Open source Total Assets: 53980000 Open source
20232023-12-31	Liabilities / assets	172.5%	Total Liabilities: 57137000 Open source Total Assets: 33119000 Open source
20242024-12-31	Liabilities / assets	122.9%	Total Liabilities: 37693000 Open source Total Assets: 30660000 Open source
20252025-12-31	Liabilities / assets	42.5%	Total Liabilities: 16512000 Open source Total Assets: 38812000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.17× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20212021-12-31	Current assets / current liabilities	10.93×	Current Assets: 82637000 Open source Current Liabilities: 7558000 Open source
20222022-12-31	Current assets / current liabilities	1.07×	Current Assets: 43926000 Open source Current Liabilities: 41200000 Open source
20232023-12-31	Current assets / current liabilities	0.45×	Current Assets: 24498000 Open source Current Liabilities: 54177000 Open source
20242024-12-31	Current assets / current liabilities	0.06×	Current Assets: 2164000 Open source Current Liabilities: 35446000 Open source
20252025-12-31	Current assets / current liabilities	0.17×	Current Assets: 2557000 Open source Current Liabilities: 14837000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2016-01-01 – 2016-12-31	−USD 5.65 million Exact value Exact value: -5650851 USD 2016-01-01 – 2016-12-31: -5650851 USD Inspect Net Income Open source Share or cite Citation for Net Income · PAVMED INC. · 2016-12-31 PAVMED INC. (edgar:1624326) Net Income: -5650851 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5650851 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000149315218003367/pavmu-20171231.xml#264661 Filing: 000149315218003367 The citation records this snapshot. The page link may show a newer release later.	−USD 4.45 million Exact value Exact value: -4454857 USD 2016-01-01 – 2016-12-31: -4454857 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PAVMED INC. · 2016-12-31 PAVMED INC. (edgar:1624326) Operating Cash Flow: -4454857 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4454857 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000149315218003367/pavmu-20171231.xml#276339 Filing: 000149315218003367 The citation records this snapshot. The page link may show a newer release later.	USD 21,793 Exact value Exact value: 21793 USD 2016-01-01 – 2016-12-31: 21793 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PAVMED INC. · 2016-12-31 PAVMED INC. (edgar:1624326) Capital Expenditure: 21793 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 21793 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000149315218003367/pavmu-20171231.xml#276745 Filing: 000149315218003367 The citation records this snapshot. The page link may show a newer release later.	−USD 4.48 million Calculation and evidence -4454857 − 21793 USD Exact free cash flow: -4476650 USD 2016-01-01 – 2016-12-31: -4454857 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 21793 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PAVMED INC. · 2016-12-31 PAVMED INC. (edgar:1624326) Free cash flow: -4476650 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4454857 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000149315218003367/pavmu-20171231.xml#276339 Filing: 000149315218003367 Input fundies:CapitalExpenditure: 21793 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000149315218003367/pavmu-20171231.xml#276745 Filing: 000149315218003367 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 9.52 million Exact value Exact value: -9519269 USD 2017-01-01 – 2017-12-31: -9519269 USD Inspect Net Income Open source Share or cite Citation for Net Income · PAVMED INC. · 2017-12-31 PAVMED INC. (edgar:1624326) Net Income: -9519269 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9519269 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000149315219004603/pavm-20181231.xml#1708474 Filing: 000149315219004603 The citation records this snapshot. The page link may show a newer release later.	−USD 6.61 million Exact value Exact value: -6608208 USD 2017-01-01 – 2017-12-31: -6608208 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PAVMED INC. · 2017-12-31 PAVMED INC. (edgar:1624326) Operating Cash Flow: -6608208 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6608208 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000149315219004603/pavm-20181231.xml#1404360 Filing: 000149315219004603 The citation records this snapshot. The page link may show a newer release later.	USD 5,301 Exact value Exact value: 5301 USD 2017-01-01 – 2017-12-31: 5301 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PAVMED INC. · 2017-12-31 PAVMED INC. (edgar:1624326) Capital Expenditure: 5301 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5301 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000149315219004603/pavm-20181231.xml#426828 Filing: 000149315219004603 The citation records this snapshot. The page link may show a newer release later.	−USD 6.61 million Calculation and evidence -6608208 − 5301 USD Exact free cash flow: -6613509 USD 2017-01-01 – 2017-12-31: -6608208 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 5301 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PAVMED INC. · 2017-12-31 PAVMED INC. (edgar:1624326) Free cash flow: -6613509 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6608208 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000149315219004603/pavm-20181231.xml#1404360 Filing: 000149315219004603 Input fundies:CapitalExpenditure: 5301 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000149315219004603/pavm-20181231.xml#426828 Filing: 000149315219004603 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 17.97 million Exact value Exact value: -17968750 USD 2018-01-01 – 2018-12-31: -17968750 USD Inspect Net Income Open source Share or cite Citation for Net Income · PAVMED INC. · 2018-12-31 PAVMED INC. (edgar:1624326) Net Income: -17968750 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -17968750 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000149315220006405/pavm-20191231.xml#918291 Filing: 000149315220006405 The citation records this snapshot. The page link may show a newer release later.	−USD 8.79 million Exact value Exact value: -8787907 USD 2018-01-01 – 2018-12-31: -8787907 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PAVMED INC. · 2018-12-31 PAVMED INC. (edgar:1624326) Operating Cash Flow: -8787907 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8787907 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000149315220006405/pavm-20191231.xml#942913 Filing: 000149315220006405 The citation records this snapshot. The page link may show a newer release later.	USD 26,609 Exact value Exact value: 26609 USD 2018-01-01 – 2018-12-31: 26609 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PAVMED INC. · 2018-12-31 PAVMED INC. (edgar:1624326) Capital Expenditure: 26609 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 26609 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000149315220006405/pavm-20191231.xml#302579 Filing: 000149315220006405 The citation records this snapshot. The page link may show a newer release later.	−USD 8.81 million Calculation and evidence -8787907 − 26609 USD Exact free cash flow: -8814516 USD 2018-01-01 – 2018-12-31: -8787907 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 26609 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PAVMED INC. · 2018-12-31 PAVMED INC. (edgar:1624326) Free cash flow: -8814516 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8787907 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000149315220006405/pavm-20191231.xml#942913 Filing: 000149315220006405 Input fundies:CapitalExpenditure: 26609 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000149315220006405/pavm-20191231.xml#302579 Filing: 000149315220006405 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 16.46 million Exact value Exact value: -16457000 USD 2019-01-01 – 2019-12-31: -16457000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PAVMED INC. · 2019-12-31 PAVMED INC. (edgar:1624326) Net Income: -16457000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16457000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000149315221006002/pavm-20201231.xml#212041 Filing: 000149315221006002 The citation records this snapshot. The page link may show a newer release later.	−USD 13.36 million Exact value Exact value: -13357000 USD 2019-01-01 – 2019-12-31: -13357000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PAVMED INC. · 2019-12-31 PAVMED INC. (edgar:1624326) Operating Cash Flow: -13357000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13357000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000149315221006002/pavm-20201231.xml#235527 Filing: 000149315221006002 The citation records this snapshot. The page link may show a newer release later.	USD 27,000 Exact value Exact value: 27000 USD 2019-01-01 – 2019-12-31: 27000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PAVMED INC. · 2019-12-31 PAVMED INC. (edgar:1624326) Capital Expenditure: 27000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 27000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000149315221006002/pavm-20201231.xml#204402 Filing: 000149315221006002 The citation records this snapshot. The page link may show a newer release later.	−USD 13.38 million Calculation and evidence -13357000 − 27000 USD Exact free cash flow: -13384000 USD 2019-01-01 – 2019-12-31: -13357000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 27000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PAVMED INC. · 2019-12-31 PAVMED INC. (edgar:1624326) Free cash flow: -13384000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13357000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000149315221006002/pavm-20201231.xml#235527 Filing: 000149315221006002 Input fundies:CapitalExpenditure: 27000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000149315221006002/pavm-20201231.xml#204402 Filing: 000149315221006002 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 34.28 million Exact value Exact value: -34276000 USD 2020-01-01 – 2020-12-31: -34276000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PAVMED INC. · 2020-12-31 PAVMED INC. (edgar:1624326) Net Income: -34276000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -34276000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000149315222009202/form10-k.htm#2908473 Filing: 000149315222009202 The citation records this snapshot. The page link may show a newer release later.	−USD 21.91 million Exact value Exact value: -21914000 USD 2020-01-01 – 2020-12-31: -21914000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PAVMED INC. · 2020-12-31 PAVMED INC. (edgar:1624326) Operating Cash Flow: -21914000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -21914000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000149315222009202/form10-k.htm#1784737 Filing: 000149315222009202 The citation records this snapshot. The page link may show a newer release later.	USD 55,000 Exact value Exact value: 55000 USD 2020-01-01 – 2020-12-31: 55000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PAVMED INC. · 2020-12-31 PAVMED INC. (edgar:1624326) Capital Expenditure: 55000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 55000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000149315222009202/form10-k.htm#1790190 Filing: 000149315222009202 The citation records this snapshot. The page link may show a newer release later.	−USD 21.97 million Calculation and evidence -21914000 − 55000 USD Exact free cash flow: -21969000 USD 2020-01-01 – 2020-12-31: -21914000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 55000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PAVMED INC. · 2020-12-31 PAVMED INC. (edgar:1624326) Free cash flow: -21969000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -21914000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000149315222009202/form10-k.htm#1784737 Filing: 000149315222009202 Input fundies:CapitalExpenditure: 55000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000149315222009202/form10-k.htm#1790190 Filing: 000149315222009202 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 50.35 million Exact value Exact value: -50347000 USD 2021-01-01 – 2021-12-31: -50347000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PAVMED INC. · 2021-12-31 PAVMED INC. (edgar:1624326) Net Income: -50347000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -50347000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000149315223007481/form10-k.htm#2266401 Filing: 000149315223007481 The citation records this snapshot. The page link may show a newer release later.	−USD 40.59 million Exact value Exact value: -40591000 USD 2021-01-01 – 2021-12-31: -40591000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PAVMED INC. · 2021-12-31 PAVMED INC. (edgar:1624326) Operating Cash Flow: -40591000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -40591000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000149315223007481/form10-k.htm#1539861 Filing: 000149315223007481 The citation records this snapshot. The page link may show a newer release later.	USD 1.47 million Exact value Exact value: 1469000 USD 2021-01-01 – 2021-12-31: 1469000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PAVMED INC. · 2021-12-31 PAVMED INC. (edgar:1624326) Capital Expenditure: 1469000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1469000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000149315223007481/form10-k.htm#1541745 Filing: 000149315223007481 The citation records this snapshot. The page link may show a newer release later.	−USD 42.06 million Calculation and evidence -40591000 − 1469000 USD Exact free cash flow: -42060000 USD 2021-01-01 – 2021-12-31: -40591000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 1469000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PAVMED INC. · 2021-12-31 PAVMED INC. (edgar:1624326) Free cash flow: -42060000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -40591000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000149315223007481/form10-k.htm#1539861 Filing: 000149315223007481 Input fundies:CapitalExpenditure: 1469000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000149315223007481/form10-k.htm#1541745 Filing: 000149315223007481 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 88.98 million Exact value Exact value: -88983000 USD 2022-01-01 – 2022-12-31: -88983000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PAVMED INC. · 2022-12-31 PAVMED INC. (edgar:1624326) Net Income: -88983000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -88983000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000149315224011172/form10-k.htm#2910705 Filing: 000149315224011172 The citation records this snapshot. The page link may show a newer release later.	−USD 70.99 million Exact value Exact value: -70985000 USD 2022-01-01 – 2022-12-31: -70985000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PAVMED INC. · 2022-12-31 PAVMED INC. (edgar:1624326) Operating Cash Flow: -70985000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -70985000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000149315224011172/form10-k.htm#1755299 Filing: 000149315224011172 The citation records this snapshot. The page link may show a newer release later.	USD 1.54 million Exact value Exact value: 1540000 USD 2022-01-01 – 2022-12-31: 1540000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PAVMED INC. · 2022-12-31 PAVMED INC. (edgar:1624326) Capital Expenditure: 1540000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1540000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000149315224011172/form10-k.htm#1760637 Filing: 000149315224011172 The citation records this snapshot. The page link may show a newer release later.	−USD 72.53 million Calculation and evidence -70985000 − 1540000 USD Exact free cash flow: -72525000 USD 2022-01-01 – 2022-12-31: -70985000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 1540000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PAVMED INC. · 2022-12-31 PAVMED INC. (edgar:1624326) Free cash flow: -72525000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -70985000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000149315224011172/form10-k.htm#1755299 Filing: 000149315224011172 Input fundies:CapitalExpenditure: 1540000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000149315224011172/form10-k.htm#1760637 Filing: 000149315224011172 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 64.18 million Exact value Exact value: -64175000 USD 2023-01-01 – 2023-12-31: -64175000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PAVMED INC. · 2023-12-31 PAVMED INC. (edgar:1624326) Net Income: -64175000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -64175000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000164117225000364/form10-k.htm#2643113 Filing: 000164117225000364 The citation records this snapshot. The page link may show a newer release later.	−USD 52.04 million Exact value Exact value: -52036000 USD 2023-01-01 – 2023-12-31: -52036000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PAVMED INC. · 2023-12-31 PAVMED INC. (edgar:1624326) Operating Cash Flow: -52036000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -52036000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000164117225000364/form10-k.htm#1805831 Filing: 000164117225000364 The citation records this snapshot. The page link may show a newer release later.	USD 242,000 Exact value Exact value: 242000 USD 2023-01-01 – 2023-12-31: 242000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PAVMED INC. · 2023-12-31 PAVMED INC. (edgar:1624326) Capital Expenditure: 242000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 242000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000164117225000364/form10-k.htm#1807670 Filing: 000164117225000364 The citation records this snapshot. The page link may show a newer release later.	−USD 52.28 million Calculation and evidence -52036000 − 242000 USD Exact free cash flow: -52278000 USD 2023-01-01 – 2023-12-31: -52036000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 242000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PAVMED INC. · 2023-12-31 PAVMED INC. (edgar:1624326) Free cash flow: -52278000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -52036000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000164117225000364/form10-k.htm#1805831 Filing: 000164117225000364 Input fundies:CapitalExpenditure: 242000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000164117225000364/form10-k.htm#1807670 Filing: 000164117225000364 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	USD 39.79 million Exact value Exact value: 39791000 USD 2024-01-01 – 2024-12-31: 39791000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PAVMED INC. · 2024-12-31 PAVMED INC. (edgar:1624326) Net Income: 39791000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: 39791000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000143774926010115/pavm20251231_10k.htm#2954932 Filing: 000143774926010115 The citation records this snapshot. The page link may show a newer release later.	−USD 33.55 million Exact value Exact value: -33554000 USD 2024-01-01 – 2024-12-31: -33554000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PAVMED INC. · 2024-12-31 PAVMED INC. (edgar:1624326) Operating Cash Flow: -33554000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -33554000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000143774926010115/pavm20251231_10k.htm#1770146 Filing: 000143774926010115 The citation records this snapshot. The page link may show a newer release later.	USD 55,000 Exact value Exact value: 55000 USD 2024-01-01 – 2024-12-31: 55000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PAVMED INC. · 2024-12-31 PAVMED INC. (edgar:1624326) Capital Expenditure: 55000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 55000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000143774926010115/pavm20251231_10k.htm#1775527 Filing: 000143774926010115 The citation records this snapshot. The page link may show a newer release later.	−USD 33.61 million Calculation and evidence -33554000 − 55000 USD Exact free cash flow: -33609000 USD 2024-01-01 – 2024-12-31: -33554000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 55000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PAVMED INC. · 2024-12-31 PAVMED INC. (edgar:1624326) Free cash flow: -33609000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -33554000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000143774926010115/pavm20251231_10k.htm#1770146 Filing: 000143774926010115 Input fundies:CapitalExpenditure: 55000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000143774926010115/pavm20251231_10k.htm#1775527 Filing: 000143774926010115 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	USD 401,000 Exact value Exact value: 401000 USD 2025-01-01 – 2025-12-31: 401000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PAVMED INC. · 2025-12-31 PAVMED INC. (edgar:1624326) Net Income: 401000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: 401000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000143774926010115/pavm20251231_10k.htm#2953936 Filing: 000143774926010115 The citation records this snapshot. The page link may show a newer release later.	−USD 5.2 million Exact value Exact value: -5200000 USD 2025-01-01 – 2025-12-31: -5200000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PAVMED INC. · 2025-12-31 PAVMED INC. (edgar:1624326) Operating Cash Flow: -5200000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5200000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000143774926010115/pavm20251231_10k.htm#1825710 Filing: 000143774926010115 The citation records this snapshot. The page link may show a newer release later.	USD 31,000 Exact value Exact value: 31000 USD 2025-01-01 – 2025-12-31: 31000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PAVMED INC. · 2025-12-31 PAVMED INC. (edgar:1624326) Capital Expenditure: 31000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 31000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000143774926010115/pavm20251231_10k.htm#1774540 Filing: 000143774926010115 The citation records this snapshot. The page link may show a newer release later.	−USD 5.23 million Calculation and evidence -5200000 − 31000 USD Exact free cash flow: -5231000 USD 2025-01-01 – 2025-12-31: -5200000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 31000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PAVMED INC. · 2025-12-31 PAVMED INC. (edgar:1624326) Free cash flow: -5231000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1624326?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5200000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000143774926010115/pavm20251231_10k.htm#1825710 Filing: 000143774926010115 Input fundies:CapitalExpenditure: 31000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1624326/000143774926010115/pavm20251231_10k.htm#1774540 Filing: 000143774926010115 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

74 filings · 2,491 latest values · 2,491 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001624326, 1624326, PAVM, edgar:1624326, pavm, pavmu

Also known as PAVMED INC., PAVMED INC., PAVMED INC., PAVmed Inc, PAVmed Inc., PAXmed Inc.

PAVMED INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation